We are live on ! Find out more
HURA

TuHURA Biosciences

5 hedge funds and large institutions have $97K invested in TuHURA Biosciences in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

29% less funds holding

Funds holding: 75 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

85% less capital invested

Capital invested by funds: $667K → $97K (-$570K)

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

HURA Hedge Fund Activity: Q3 2018 in Review

5 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2018, worth a combined $97K — down 85% from $667K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of HURA and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, adding an estimated $10.8K. The largest seller was Franklin Resources, exiting entirely with an estimated $551K sold.

  • 5 institutional investors held TuHURA Biosciences (HURA) as of Q3 2018, down from 7 in Q2 2018.
  • Funds reported $97K of TuHURA Biosciences stock for Q3 2018, down 85% quarter-over-quarter.
  • 1 fund opened new TuHURA Biosciences positions in Q3 2018 and 3 closed out, a net change of -2 holders.
  • The largest TuHURA Biosciences buyer in Q3 2018 was Citadel Advisors, an estimated $10.8K added.
  • The largest TuHURA Biosciences seller in Q3 2018 was Franklin Resources, an estimated $551K sold.

Based on aggregated 13F filings for Q3 2018.